Standard
Federal Regulators Clear Biometric Tool to Aid Clinicians in Autism Diagnosis
Federal regulators have cleared a novel diagnostic assistance tool designed to help clinicians identify autism spectrum disorder in children, marking another step forward in the integration of artificial intelligence and biometrics into pediatric healthcare. The Food and Drug Administration cleared Neurora this month, authorizing its use to inform clinical decisions when evaluating children and adolescents…
